FDA authorizes new COVID-19 vaccine — and it’s not like the others
The FDA has issued an emergency use authorization for biotech company Novavax’s protein-based COVID-19 vaccine.
We may want to rethink how we deliver COVID-19 vaccines
An inhaled vaccine outperformed a nasal spray in an animal study, suggesting that the delivery method could deserve more attention.
New test tells you how many T cells for COVID-19 you have
A new blood test that measures a key indicator of COVID-19 immunity could help you assess your risk of a coronavirus infection.
Handheld antibody tester could reveal if you’re immune to COVID
Hong Kong researchers have developed a handheld COVID antibody testing device more capable than current home tests.
The US Civil War drastically reshaped how Americans deal with death – will the pandemic?
How do American's attitudes towards death change when they are confronted with such enormous losses?
Nanoparticles are the future of medicine
The success of some drugs that use nanoparticles, such as the COVID-19 mRNA vaccines, has prompted excitement among researchers.
Will new vaccines be better at fighting coronavirus variants?
New virus-based vaccines could play an important role in generating a long-lasting, broad immunity against a rapidly mutating virus.
Moderna expects to have Omicron booster ready by Fall 2022
Moderna expects to have an Omicron booster that combines its original COVID-19 vaccine with one targeting the variant ready by Fall 2022.
Moderna applies for approval of COVID-19 vaccine for children
Moderna has asked the FDA to authorize its COVID-19 vaccine for children ages 6 months through 5 years.